首页>
外国专利>
Oncolytic adenoviral vectors coding for monoclonal anti - CTLA - 4 antibodies
Oncolytic adenoviral vectors coding for monoclonal anti - CTLA - 4 antibodies
展开▼
机译:编码单克隆抗CTLA-4抗体的溶瘤腺病毒载体
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the fields of life sciences and medicine. Specifically, the invention relates to cancer therapies. More specifically, the present invention relates to oncolytic adenoviral vectors and cells and pharmaceutical compositions comprising said vectors. The present invention also relates to said vectors for treating cancer in a subject and a method of treating cancer in a subject. Furthermore, the present invention relates to methods of producing monoclonal anti-CTLA4 antibodies in a cell and increasing tumor specific immune response and apoptosis in a subject, as well as uses of the oncolytic adenoviral vectors for producing monoclonal anti-CTLA4 antibodies in a cell and increasing tumor specific immune response and apoptosis in a subject.
展开▼